These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma. Vyas M; Hechtman JF; Zhang Y; Benayed R; Yavas A; Askan G; Shia J; Klimstra DS; Basturk O Mod Pathol; 2020 Apr; 33(4):648-656. PubMed ID: 31676785 [TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma. Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495 [TBL] [Abstract][Full Text] [Related]
7. Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1. Shirani M; Levin S; Shebl B; Requena D; Finkelstein TM; Johnson DS; Ng D; Lalazar G; Heissel S; Hojrup P; Molina H; de Jong YP; Rice CM; Singhi AD; Torbenson MS; Coffino P; Lyons B; Simon SM Cancer Res; 2024 Aug; 84(16):2626-2644. PubMed ID: 38888469 [TBL] [Abstract][Full Text] [Related]
8. Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion. Graham RP; Lackner C; Terracciano L; González-Cantú Y; Maleszewski JJ; Greipp PT; Simon SM; Torbenson MS Hepatology; 2018 Oct; 68(4):1441-1447. PubMed ID: 29222914 [TBL] [Abstract][Full Text] [Related]
9. Single-Cell RNA Sequencing Identifies Yes-Associated Protein 1-Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma. Jewell ML; Gibson JR; Guy CD; Hyun J; Du K; Oh SH; Premont RT; Hsu DS; Ribar T; Gregory SG; Diehl AME Am J Pathol; 2020 Jan; 190(1):93-107. PubMed ID: 31669305 [TBL] [Abstract][Full Text] [Related]
10. A genomic case study of mixed fibrolamellar hepatocellular carcinoma. Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J; Demeter R; Graves T; Eldred JM; Walker J; Larson DE; Maher CA; Lin Y; Chapman W; Mahadevan A; Miksad R; Nasser I; Hanto DW; Mardis ER Ann Oncol; 2016 Jun; 27(6):1148-1154. PubMed ID: 27029710 [TBL] [Abstract][Full Text] [Related]
11. GalNAc-conjugated siRNA targeting the DNAJB1-PRKACA fusion junction in fibrolamellar hepatocellular carcinoma. Neumayer C; Ng D; Requena D; Jiang CS; Qureshi A; Vaughan R; Prakash TP; Revenko A; Simon SM Mol Ther; 2024 Jan; 32(1):140-151. PubMed ID: 37980543 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA. Neumayer C; Ng D; Jiang CS; Qureshi A; Lalazar G; Vaughan R; Simon SM Clin Cancer Res; 2023 Jan; 29(1):271-278. PubMed ID: 36302174 [TBL] [Abstract][Full Text] [Related]
13. Transcriptomic characterization of fibrolamellar hepatocellular carcinoma. Simon EP; Freije CA; Farber BA; Lalazar G; Darcy DG; Honeyman JN; Chiaroni-Clarke R; Dill BD; Molina H; Bhanot UK; La Quaglia MP; Rosenberg BR; Simon SM Proc Natl Acad Sci U S A; 2015 Nov; 112(44):E5916-25. PubMed ID: 26489647 [TBL] [Abstract][Full Text] [Related]
14. DNAJB1-PRKACA is specific for fibrolamellar carcinoma. Graham RP; Jin L; Knutson DL; Kloft-Nelson SM; Greipp PT; Waldburger N; Roessler S; Longerich T; Roberts LR; Oliveira AM; Halling KC; Schirmacher P; Torbenson MS Mod Pathol; 2015 Jun; 28(6):822-9. PubMed ID: 25698061 [TBL] [Abstract][Full Text] [Related]
15. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma. Bauer J; Köhler N; Maringer Y; Bucher P; Bilich T; Zwick M; Dicks S; Nelde A; Dubbelaar M; Scheid J; Wacker M; Heitmann JS; Schroeder S; Rieth J; Denk M; Richter M; Klein R; Bonzheim I; Luibrand J; Holzer U; Ebinger M; Brecht IB; Bitzer M; Boerries M; Feucht J; Salih HR; Rammensee HG; Hailfinger S; Walz JS Nat Commun; 2022 Oct; 13(1):6401. PubMed ID: 36302754 [TBL] [Abstract][Full Text] [Related]
16. Identification of Long Non-Coding RNA Profiles and Potential Therapeutic Agents for Fibrolamellar Carcinoma Based on RNA-Sequencing Data. Kim J; Kim Y; Lee B Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761849 [TBL] [Abstract][Full Text] [Related]